Profound Medical (PROF) Shares Outstanding (Weighted Average) (2018 - 2026)

Profound Medical has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $36.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 20.82% year-over-year to $36.3 million; the trailing twelve-month figure through Mar 2026 stood at $36.3 million (up 20.82% YoY), and the FY2025 full-year result was $30.2 million, up 22.08% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $36.3 million, up from $30.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $222.8 billion in Q1 2022, with the low at $772270.0 in Q4 2022.
• Average Shares Outstanding (Weighted Average) over 5 years is $25.5 billion, with a median of $203.4 million recorded in 2022.
• Year-over-year, Shares Outstanding (Weighted Average) surged 2642.9% in 2023 and plunged 99.89% in 2024.
• Tracing PROF's Shares Outstanding (Weighted Average) over 5 years: stood at $772270.0 in 2022, then surged by 2642.9% to $21.2 million in 2023, then increased by 16.91% to $24.8 million in 2024, then increased by 22.08% to $30.2 million in 2025, then increased by 20.06% to $36.3 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $36.3 million (Q1 2026), $30.2 million (Q4 2025), and $30.1 million (Q3 2025), per Business Quant data.

Peer Comparison